http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106565551-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-08 |
| filingDate | 2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106565551-B |
| titleOfInvention | A kind of new dipropyl oxygen phenyl-methane-sulfonamide class adjusts the compound and its medical usage of estrogen-related receptor activity |
| abstract | The invention discloses the compound and its pharmaceutically acceptable salt of a kind of new dipropyl oxygen phenyl methanesulfonamide amides adjusting estrogen-related receptor activity with Formulas I and its applications.The compound and its pharmaceutically acceptable salt, which can be used for preparing having, adjusts estrogen-related receptor ERR alpha（Estrogen related receptor alpha, ERR alpha or ERR α）Activity, the drug of the malignant tumours such as prevention and treatment breast cancer, prostate cancer, stomach cancer, colon cancer, oophoroma, cervical carcinoma. |
| priorityDate | 2016-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 162.